DXSE:F:F-Xtrackers Stoxx Europe 600 Health Care Swap UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 231.95

Change

+1.30 (+0.56)%

Market Cap

USD 0.15B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-13 )

Largest Industry Peers for Others

ETFs Containing DXSE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.45% 84% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.45% 82% B 67% D+
Trailing 12 Months  
Capital Gain 10.37% 54% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.37% 52% F 55% F
Trailing 5 Years  
Capital Gain 73.75% 85% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 73.75% 85% B 65% D
Average Annual (5 Year Horizon)  
Capital Gain 8.67% 77% C+ 73% C
Dividend Return 8.67% 76% C+ 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.36% 67% D+ 86% B+
Risk Adjusted Return 103.68% 99% N/A 97% N/A
Market Capitalization 0.15B 35% F 35% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.